Yashou Guo

A dual-wavelength blue laser platform for integrated diagnosis and therapy in glioblastoma: preclinical evidence

Glioblastoma (GBM) remains clinically intractable owing to dismal prognosis and frequent recurrence. This study aimed to develop a dual-wavelength blue laser platform (450 nm and 405 nm) that integrates laser ablation, photodynamic diagnosis (PDD), and photodynamic therapy (PDT)...